×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [9]
Faculty of Healt... [6]
THE STATE KEY LA... [6]
Authors
LEUNG CHUNG HANG [4]
WANG YITAO [2]
LUO QIAN [2]
CHEN XIUPING [2]
LI PENG [1]
SAN MING WANG [1]
More...
Document Type
Journal article [14]
Date Issued
2024 [1]
2023 [3]
2022 [5]
2021 [1]
2020 [1]
2018 [1]
More...
Language
英語English [13]
Source Publication
Genes & Diseases [2]
ANGEWANDTE CHEMI... [1]
Acta Pharmaceuti... [1]
Advanced Science [1]
Biomaterials [1]
Blackwell Publis... [1]
More...
Indexed By
SCIE [13]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 14
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Probing the AFF4–CCNT1 protein–protein interaction using a metal–organic conjugate for treating triple-negative breast cancer
Journal article
Song, Ying Qi, Xu, Yiwen, Yang, Li Jun, Wang, Ling, Jing, Shaozhen, Yang, Guan Jun, Shiu-Hin Chan, Daniel, Wong, Chun Yuen, Wang, Wanhe, Kam Wai Wong, Vincent, Leung, Chung Hang. Probing the AFF4–CCNT1 protein–protein interaction using a metal–organic conjugate for treating triple-negative breast cancer[J]. Chemical Engineering Journal, 2024, 496, 153685.
Authors:
Song, Ying Qi
;
Xu, Yiwen
;
Yang, Li Jun
;
Wang, Ling
;
Jing, Shaozhen
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
13.3
/
13.2
|
Submit date:2024/08/05
Aff4
Ccnt1
Metal–organic Conjugate
Protein–protein Interaction
Triple-negative Breast Cancer
The interaction between macrophages and triple-negative breast cancer cells induces ROS-mediated interleukin 1α expression to enhance tumorigenesis and metastasis
Journal article
Meng Hao, Bin Huang,, Renfei Wu, Zheng Peng, Luo, Kathy Qian. The interaction between macrophages and triple-negative breast cancer cells induces ROS-mediated interleukin 1α expression to enhance tumorigenesis and metastasis[J]. Advanced Science, 2023, 10(29), 2302857.
Authors:
Meng Hao
;
Bin Huang,
;
Renfei Wu
;
Zheng Peng
;
Luo, Kathy Qian
Favorite
|
TC[WOS]:
5
TC[Scopus]:
5
IF:
14.3
/
16.3
|
Submit date:2023/08/23
Co-culture
Interleukin 1 Alpha(Il1 Alpha)
Macrophages
Metastasis
Reactive Oxygen Species (Ros)
Triple-negative Breast Cancer (Tnbc)
Etiological roles of core promoter variation in triple-negative breast cancer
Journal article
Huang, Teng, Li, Jiaheng, Wang, San Ming. Etiological roles of core promoter variation in triple-negative breast cancer[J]. Genes & Diseases, 2023, 10(1), 228 - 238.
Authors:
Huang, Teng
;
Li, Jiaheng
;
Wang, San Ming
Favorite
|
TC[WOS]:
2
TC[Scopus]:
3
IF:
6.9
/
7.2
|
Submit date:2022/05/17
Core Promoter
Rna-seq
Triple-negative Breast Cancer
Variation
Whole Exome Sequencing
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer
Journal article
Wang, Yan, Zhang, Chen, Xiao, Meng, Ganesan, Kumar, Gao, Fei, Liu, Qingqing, Ye, Zhen, Sui, Yue, Zhang, Feng, Wei, Kunhua, Wu, Yaobin, Wu, Jianmin, Du, Bing, Xu, Cong, Li, Yan, Li, Peng, Zhang, Jinming, Chen, Jianping. A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:
Wang, Yan
;
Zhang, Chen
;
Xiao, Meng
;
Ganesan, Kumar
;
Gao, Fei
; et al.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
12
IF:
4.5
/
4.7
|
Submit date:2023/02/01
Isoliquiritigenin
Zein-phosphatidylcholine Hybrid Nanoparticles
Bioavailability
Triple-negative Breast Cancer
Safe Therapeutic Strategy
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer
Journal article
Liu, Xinkui, Bai, Meirong, Li, Huiying, Ye, Peizhi, Duan, Xiaoxia, Wu, Chao, Huang, Zhihong, Lu, Shan, Zhang, Jingyuan, Zhao, Zihan, Guo, Fengying, You, Rongli, Qin, Wenjie, Wang, Wei, Han, Aiqing, Shen, Liangliang, Wang, Yitao, Zhao, Zheng, Luo, Hua, Wu, Jiarui. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer[J]. Frontiers in Immunology, 2022, 13.
Authors:
Liu, Xinkui
;
Bai, Meirong
;
Li, Huiying
;
Ye, Peizhi
;
Duan, Xiaoxia
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
5.7
/
6.8
|
Submit date:2022/12/01
Compound Kushen Injection
Triple-negative Breast Cancer
Single Cell Rna-sequencing
t Lymphocytes
Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1
Journal article
Wei, Chunli, Khan, Md Asaduzzaman, Du, Jiaman, Cheng, Jingliang, Tania, Mousumi, Elaine Lai-Han Leung, Fu, Junjiang. Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1[J]. Frontiers in Oncology, 2022, 12.
Authors:
Wei, Chunli
;
Khan, Md Asaduzzaman
;
Du, Jiaman
;
Cheng, Jingliang
;
Tania, Mousumi
; et al.
Favorite
|
TC[WOS]:
25
TC[Scopus]:
26
IF:
3.5
/
4.0
|
Submit date:2023/01/30
Cancer Therapeutics
Cell Migration And Invasion
Cordycepin
Slug
Triple-negative Breast Cancer (Tnbc)
Twist1
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
Journal article
Zhang, Shuang, Dong, Yu, Chen, Xiuping, Tan, Chris Soon Heng, Li, Min, Miao, Kai, Lu, Jia Hong. Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy[J]. Chinese Medicine, 2022, 17, 55.
Authors:
Zhang, Shuang
;
Dong, Yu
;
Chen, Xiuping
;
Tan, Chris Soon Heng
;
Li, Min
; et al.
Favorite
|
TC[WOS]:
11
TC[Scopus]:
12
IF:
5.3
/
5.5
|
Submit date:2022/05/31
Apoptosis
Autophagy Inhibition
Irinotecan
Lysosome
Sn-38
Toosendanin
Triple-negative Breast Cancer
Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer
Journal article
Cheng, Sha Sha, Qu, Yuan Qing, Wu, Jia, Yang, Guan Jun, Liu, Hao, Wang, Wanhe, Huang, Qi, Chen, Feng, Li, Guodong, Wong, Chun Yuen, Wong, Vincent Kam Wai, Ma, Dik Lung, Leung, Chung Hang. Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer[J]. Acta Pharmaceutica Sinica B, 2022, 12(3), 1390-1405.
Authors:
Cheng, Sha Sha
;
Qu, Yuan Qing
;
Wu, Jia
;
Yang, Guan Jun
;
Liu, Hao
; et al.
Favorite
|
TC[WOS]:
36
TC[Scopus]:
39
IF:
14.7
/
14.1
|
Submit date:2022/04/06
Epigenetics
Kinase Inhibitor
Metal Complex
Metastasis
Protein–protein Interaction
Triple-negative Breast Cancer
High Expression of G6PD Increases Doxorubicin Resistance in Triple Negative Breast Cancer Cells by Maintaining GSH Level
Journal article
Luo, Man, Fu, Afu, Wu, Renfei, Wei, Na, Song, Kai, Lim, Sierin, Luo, Kathy Qian. High Expression of G6PD Increases Doxorubicin Resistance in Triple Negative Breast Cancer Cells by Maintaining GSH Level[J]. International Journal of Biological Sciences, 2022, 18(3), 1120-1133.
Authors:
Luo, Man
;
Fu, Afu
;
Wu, Renfei
;
Wei, Na
;
Song, Kai
; et al.
Favorite
|
TC[WOS]:
29
TC[Scopus]:
27
IF:
8.2
/
8.3
|
Submit date:2022/05/17
Doxorubicin
Drug Resistance
G6pd
Metastasis
Oxidative Stress
Triple Negative Breast Cancer
Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
Journal article
Shasha Cheng, Guan-Jun Yang, Wanhe Wang, Dik-Lung Ma, Chung-Hang Leung. Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells[J]. Genes & Diseases, 2021, 9(6), 1674-1688.
Authors:
Shasha Cheng
;
Guan-Jun Yang
;
Wanhe Wang
;
Dik-Lung Ma
;
Chung-Hang Leung
Favorite
|
TC[WOS]:
23
TC[Scopus]:
26
IF:
6.9
/
7.2
|
Submit date:2022/05/13
Cancer Stem Cells
Cdk9-cyclin T1
Epithelial Mesenchymal Transition
Protein–protein Interaction (Ppi)
Triple-negative Breast Cancer (Tnbc)